Controlled substances; psychoactive derivatives of hemp added as Schedule I drug

SB 132 would reclassify psychoactive cannabinoids derived from hemp (such as Delta-8, Delta-9, and Delta-10 THC) as Schedule I controlled substances, removing their current exemption under Alabama law. This change would directly affect businesses selling these products, as they would now face the same legal restrictions as other Schedule I drugs. The bill also repeals existing rules that prohibited selling these products to minors. The policy change specifically targets psychoactive hemp derivatives while maintaining exemptions for non-psychoactive cannabinoids.